English

BIOMERICA, INC.

EDGAR

BMRA Quarterly report (10-Q) · filed 2026-10-15

Annual consolidated revenue for 2026: about USD 4.453M, using the latest reported figures. The previous period, 2025, was about USD 5.311M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.27 million USD

2027 Q1 · USD

Exact inputs and evidence

Revenue: 1265000 USD Source

Operating margin

-97%

2027 Q1 · %

Exact inputs and evidence

Operating Income: -1227000 USD Source
Revenue: 1265000 USD Source

Operating cash flow

-802 thousand USD

2027 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -802000 USD Source

Cash and cash equivalents: 2.73 million USD 2026-08-31 Source
Exact value

2733000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 4.6 million shares 2026-08-31 Source
Exact value

4598968 shares

Reported share-count change

63.35% · 1.78 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

2815410 shares · 2025-08-31· Source
4598968 shares · 2026-08-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.34 million USD

2025-09-01 – 2026-08-31

Exact inputs and evidence

Revenue: 1210000 USD · 2025-09-01 – 2025-11-30 Source
Revenue: 987000 USD · 2025-12-01 – 2026-02-28 Source
Revenue: 4453000 USD · 2025-06-01 – 2026-05-31 Source
Revenue: 3578000 USD · 2025-06-01 – 2026-02-28 Source
Revenue: 1265000 USD · 2026-06-01 – 2026-08-31 Source

Net income

-5.01 million USD

2025-09-01 – 2026-08-31

Exact inputs and evidence

Net income: -1320000 USD · 2025-09-01 – 2025-11-30 Source
Net income: -1312000 USD · 2025-12-01 – 2026-02-28 Source
Net income: -3775000 USD · 2025-06-01 – 2026-05-31 Source
Net income: -2630000 USD · 2025-06-01 – 2026-02-28 Source
Net income: -1232000 USD · 2026-06-01 – 2026-08-31 Source

Operating cash flow

-3.96 million USD

2025-09-01 – 2026-08-31

Exact inputs and evidence

Operating cash flow: -1259000 USD · 2025-06-01 – 2025-11-30 Source
Operating cash flow: -268000 USD · 2025-06-01 – 2025-08-31 Source
Operating cash flow: -2509000 USD · 2025-06-01 – 2026-02-28 Source
Operating cash flow: -1259000 USD · 2025-06-01 – 2025-11-30 Source
Operating cash flow: -3421000 USD · 2025-06-01 – 2026-05-31 Source
Operating cash flow: -2509000 USD · 2025-06-01 – 2026-02-28 Source
Operating cash flow: -802000 USD · 2026-06-01 – 2026-08-31 Source

Capital expenditure

51 thousand USD

2023-06-01 – 2024-05-31

Exact inputs and evidence

Capital expenditure: 21000 USD · 2023-06-01 – 2023-08-31 Source
Capital expenditure: 27000 USD · 2023-06-01 – 2023-11-30 Source
Capital expenditure: 21000 USD · 2023-06-01 – 2023-08-31 Source
Capital expenditure: 27000 USD · 2023-06-01 – 2024-02-29 Source
Capital expenditure: 27000 USD · 2023-06-01 – 2023-11-30 Source
Capital expenditure: 51000 USD · 2023-06-01 – 2024-05-31 Source
Capital expenditure: 27000 USD · 2023-06-01 – 2024-02-29 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-15.

Financial data available through: 2026-05-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2026-05-31
Operating income: 11 of 11 periods available· newest 2026-05-31
Net income: 11 of 11 periods available· newest 2026-05-31
Operating cash flow: 11 of 11 periods available· newest 2026-05-31
Capital expenditure: 9 of 11 periods available· newest 2024-05-31
Total assets: 11 of 11 periods available· newest 2026-05-31
Total liabilities: 8 of 11 periods available· newest 2026-05-31
Current assets: 11 of 11 periods available· newest 2026-05-31
Current liabilities: 11 of 11 periods available· newest 2026-05-31
Cash and cash equivalents: 11 of 11 periods available· newest 2026-05-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2026-05-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-16.2%

Prior period

USD 5.31 million

2024-06-01 – 2025-05-31
Current period

USD 4.45 million

2025-06-01 – 2026-05-31

Exact inputs and evidence

4453000 − 5311000 = -858000 USD

5311000 USD · 2024-06-01 – 2025-05-31
Inspect prior input Prior source
4453000 USD · 2025-06-01 – 2026-05-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOMERICA, INC. · 2026-05-31 BIOMERICA, INC. (edgar:73290) Year-over-year change in Revenue: -858000 USD Concept: fundies:Revenue Period: 2025-06-01 to 2026-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4453000 USD (2025-06-01 to 2026-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#1241239 Filing: 000149315226040851 Input fundies:Revenue: 5311000 USD (2024-06-01 to 2025-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#1242142 Filing: 000149315226040851
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 1.2 million

Prior period

−USD 4.97 million

2024-06-01 – 2025-05-31
Current period

−USD 3.78 million

2025-06-01 – 2026-05-31

Exact inputs and evidence

-3775000 − -4973000 = 1198000 USD

-4973000 USD · 2024-06-01 – 2025-05-31
Inspect prior input Prior source
-3775000 USD · 2025-06-01 – 2026-05-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOMERICA, INC. · 2026-05-31 BIOMERICA, INC. (edgar:73290) Year-over-year change in Net income: 1198000 USD Concept: fundies:NetIncome Period: 2025-06-01 to 2026-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3775000 USD (2025-06-01 to 2026-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#1040103 Filing: 000149315226040851 Input fundies:NetIncome: -4973000 USD (2024-06-01 to 2025-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#1040542 Filing: 000149315226040851
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 421,000

Prior period

−USD 3.84 million

2024-06-01 – 2025-05-31
Current period

−USD 3.42 million

2025-06-01 – 2026-05-31

Exact inputs and evidence

-3421000 − -3842000 = 421000 USD

-3842000 USD · 2024-06-01 – 2025-05-31
Inspect prior input Prior source
-3421000 USD · 2025-06-01 – 2026-05-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOMERICA, INC. · 2026-05-31 BIOMERICA, INC. (edgar:73290) Year-over-year change in Operating cash flow: 421000 USD Concept: fundies:OperatingCashFlow Period: 2025-06-01 to 2026-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3421000 USD (2025-06-01 to 2026-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#850844 Filing: 000149315226040851 Input fundies:OperatingCashFlow: -3842000 USD (2024-06-01 to 2025-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#851307 Filing: 000149315226040851
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-06-01 – 2026-05-31

Revenue USD 4.45 million 100% of revenue
Cost of revenue USD 4.09 million 92% of revenue
Operating expenses USD 5.68 million 128% of revenue
Operating income −USD 5.32 million −119% of revenue
Tax, interest and other Derived −USD 1.55 million −35% of revenue
Net income −USD 3.78 million −85% of revenue

Cash

Operating cash flow −USD 3.42 million −77% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 116% of revenue.
2018 Operating loss: operating costs were 127% of revenue.
2019 Operating loss: operating costs were 146% of revenue.
2020 Operating loss: operating costs were 141% of revenue.
2021 Operating loss: operating costs were 204% of revenue.
2022 Operating loss: operating costs were 124% of revenue.
2023 Operating loss: operating costs were 235% of revenue.
2024 Operating loss: operating costs were 218% of revenue.
2025 Operating loss: operating costs were 197% of revenue.
2026 Operating loss: operating costs were 219% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2016-06-01 – 2017-05-31	5791670	6746303 Derived	-954633	-46072 Derived	-908561	-818943 Derived	Source 2016-06-01 – 2017-05-31: 5791670 USD Inspect Revenue Open source 2016-06-01 – 2017-05-31: -954633 USD Inspect Operating Income Open source 2016-06-01 – 2017-05-31: -908561 USD Inspect Net Income Open source 2016-06-01 – 2017-05-31: -722858 USD Inspect Operating Cash Flow Open source 2016-06-01 – 2017-05-31: 96085 USD Inspect Capital Expenditure Open source
2018 2017-06-01 – 2018-05-31	5564185	7045940 Derived	-1481755	-15927 Derived	-1465828	-1304564 Derived	Source 2017-06-01 – 2018-05-31: 5564185 USD Inspect Revenue Open source 2017-06-01 – 2018-05-31: -1481755 USD Inspect Operating Income Open source 2017-06-01 – 2018-05-31: -1465828 USD Inspect Net Income Open source 2017-06-01 – 2018-05-31: -1174217 USD Inspect Operating Cash Flow Open source 2017-06-01 – 2018-05-31: 130347 USD Inspect Capital Expenditure Open source
2019 2018-06-01 – 2019-05-31	5200682	7613472 Derived	-2412790	-19730 Derived	-2393060	-2345176 Derived	Source 2018-06-01 – 2019-05-31: 5200682 USD Inspect Revenue Open source 2018-06-01 – 2019-05-31: -2412790 USD Inspect Operating Income Open source 2018-06-01 – 2019-05-31: -2393060 USD Inspect Net Income Open source 2018-06-01 – 2019-05-31: -2244039 USD Inspect Operating Cash Flow Open source 2018-06-01 – 2019-05-31: 101137 USD Inspect Capital Expenditure Open source
2020 2019-06-01 – 2020-05-31	6693000	9433965 Derived	-2740965	-63794 Derived	-2677171	-4331106 Derived	Source 2019-06-01 – 2020-05-31: 6693000 USD Inspect Revenue Open source 2019-06-01 – 2020-05-31: -2740965 USD Inspect Operating Income Open source 2019-06-01 – 2020-05-31: -2677171 USD Inspect Net Income Open source 2019-06-01 – 2020-05-31: -4297498 USD Inspect Operating Cash Flow Open source 2019-06-01 – 2020-05-31: 33608 USD Inspect Capital Expenditure Open source
2021 2020-06-01 – 2021-05-31	7199000	14698693 Derived	-7499693	-53439 Derived	-7446254	-5387604 Derived	Source 2020-06-01 – 2021-05-31: 7199000 USD Inspect Revenue Open source 2020-06-01 – 2021-05-31: -7499693 USD Inspect Operating Income Open source 2020-06-01 – 2021-05-31: -7446254 USD Inspect Net Income Open source 2020-06-01 – 2021-05-31: -5251748 USD Inspect Operating Cash Flow Open source 2020-06-01 – 2021-05-31: 135856 USD Inspect Capital Expenditure Open source
2022 2021-06-01 – 2022-05-31	18871000	23405000 Derived	-4534000	-3000 Derived	-4531000	-536000 Derived	Source 2021-06-01 – 2022-05-31: 18871000 USD Inspect Revenue Open source 2021-06-01 – 2022-05-31: -4534000 USD Inspect Operating Income Open source 2021-06-01 – 2022-05-31: -4531000 USD Inspect Net Income Open source 2021-06-01 – 2022-05-31: -479000 USD Inspect Operating Cash Flow Open source 2021-06-01 – 2022-05-31: 57000 USD Inspect Capital Expenditure Open source
2023 2022-06-01 – 2023-05-31	5339000	12562000 Derived	-7223000	-83000 Derived	-7140000	-5538000 Derived	Source 2022-06-01 – 2023-05-31: 5339000 USD Inspect Revenue Open source 2022-06-01 – 2023-05-31: -7223000 USD Inspect Operating Income Open source 2022-06-01 – 2023-05-31: -7140000 USD Inspect Net Income Open source 2022-06-01 – 2023-05-31: -5474000 USD Inspect Operating Cash Flow Open source 2022-06-01 – 2023-05-31: 64000 USD Inspect Capital Expenditure Open source
2024 2023-06-01 – 2024-05-31	5415000	11782000 Derived	-6367000	-389000 Derived	-5978000	-5412000 Derived	Source 2023-06-01 – 2024-05-31: 5415000 USD Inspect Revenue Open source 2023-06-01 – 2024-05-31: -6367000 USD Inspect Operating Income Open source 2023-06-01 – 2024-05-31: -5978000 USD Inspect Net Income Open source 2023-06-01 – 2024-05-31: -5361000 USD Inspect Operating Cash Flow Open source 2023-06-01 – 2024-05-31: 51000 USD Inspect Capital Expenditure Open source
2025 2024-06-01 – 2025-05-31	5311000	10448000 Derived	-5137000	-164000 Derived	-4973000	Unavailable	Source 2024-06-01 – 2025-05-31: 5311000 USD Inspect Revenue Open source 2024-06-01 – 2025-05-31: -5137000 USD Inspect Operating Income Open source 2024-06-01 – 2025-05-31: -4973000 USD Inspect Net Income Open source 2024-06-01 – 2025-05-31: -3842000 USD Inspect Operating Cash Flow Open source
2026 2025-06-01 – 2026-05-31	4453000	9773000 Derived	-5320000	-1545000 Derived	-3775000	Unavailable	Source 2025-06-01 – 2026-05-31: 4453000 USD Inspect Revenue Open source 2025-06-01 – 2026-05-31: -5320000 USD Inspect Operating Income Open source 2025-06-01 – 2026-05-31: -3775000 USD Inspect Net Income Open source 2025-06-01 – 2026-05-31: -3421000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.5M 2026

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-05-31	Revenue	5791670	Revenue: 5791670 Open source
20182018-05-31	Revenue	5564185	Revenue: 5564185 Open source
20192019-05-31	Revenue	5200682	Revenue: 5200682 Open source
20202020-05-31	Revenue	6693000	Revenue: 6693000 Open source
20212021-05-31	Revenue	7199000	Revenue: 7199000 Open source
20222022-05-31	Revenue	18871000	Revenue: 18871000 Open source
20232023-05-31	Revenue	5339000	Revenue: 5339000 Open source
20242024-05-31	Revenue	5415000	Revenue: 5415000 Open source
20252025-05-31	Revenue	5311000	Revenue: 5311000 Open source
20262026-05-31	Revenue	4453000	Revenue: 4453000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-16.2% 2026

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-05-31	Year over year	12.7%	Revenue: 5791670 Open source Revenue: 5139816 Open source
20182018-05-31	Year over year	-3.9%	Revenue: 5564185 Open source Revenue: 5791670 Open source
20192019-05-31	Year over year	-6.5%	Revenue: 5200682 Open source Revenue: 5564185 Open source
20202020-05-31	Year over year	28.7%	Revenue: 6693000 Open source Revenue: 5200682 Open source
20212021-05-31	Year over year	7.6%	Revenue: 7199000 Open source Revenue: 6693000 Open source
20222022-05-31	Year over year	162.1%	Revenue: 18871000 Open source Revenue: 7199000 Open source
20232023-05-31	Year over year	-71.7%	Revenue: 5339000 Open source Revenue: 18871000 Open source
20242024-05-31	Year over year	1.4%	Revenue: 5415000 Open source Revenue: 5339000 Open source
20252025-05-31	Year over year	-1.9%	Revenue: 5311000 Open source Revenue: 5415000 Open source
20262026-05-31	Year over year	-16.2%	Revenue: 4453000 Open source Revenue: 5311000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -119.5% 2026

Net margin -84.8% 2026

Free cash flow margin -99.9% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-05-31	Operating margin	-16.5%	Operating Income: -954633 Open source Revenue: 5791670 Open source
20182018-05-31	Operating margin	-26.6%	Operating Income: -1481755 Open source Revenue: 5564185 Open source
20192019-05-31	Operating margin	-46.4%	Operating Income: -2412790 Open source Revenue: 5200682 Open source
20202020-05-31	Operating margin	-41%	Operating Income: -2740965 Open source Revenue: 6693000 Open source
20212021-05-31	Operating margin	-104.2%	Operating Income: -7499693 Open source Revenue: 7199000 Open source
20222022-05-31	Operating margin	-24%	Operating Income: -4534000 Open source Revenue: 18871000 Open source
20232023-05-31	Operating margin	-135.3%	Operating Income: -7223000 Open source Revenue: 5339000 Open source
20242024-05-31	Operating margin	-117.6%	Operating Income: -6367000 Open source Revenue: 5415000 Open source
20252025-05-31	Operating margin	-96.7%	Operating Income: -5137000 Open source Revenue: 5311000 Open source
20262026-05-31	Operating margin	-119.5%	Operating Income: -5320000 Open source Revenue: 4453000 Open source
20172017-05-31	Net margin	-15.7%	Net Income: -908561 Open source Revenue: 5791670 Open source
20182018-05-31	Net margin	-26.3%	Net Income: -1465828 Open source Revenue: 5564185 Open source
20192019-05-31	Net margin	-46%	Net Income: -2393060 Open source Revenue: 5200682 Open source
20202020-05-31	Net margin	-40%	Net Income: -2677171 Open source Revenue: 6693000 Open source
20212021-05-31	Net margin	-103.4%	Net Income: -7446254 Open source Revenue: 7199000 Open source
20222022-05-31	Net margin	-24%	Net Income: -4531000 Open source Revenue: 18871000 Open source
20232023-05-31	Net margin	-133.7%	Net Income: -7140000 Open source Revenue: 5339000 Open source
20242024-05-31	Net margin	-110.4%	Net Income: -5978000 Open source Revenue: 5415000 Open source
20252025-05-31	Net margin	-93.6%	Net Income: -4973000 Open source Revenue: 5311000 Open source
20262026-05-31	Net margin	-84.8%	Net Income: -3775000 Open source Revenue: 4453000 Open source
20172017-05-31	Free cash flow margin	-14.1%	Revenue: 5791670 Open source Operating Cash Flow: -722858 Open source Capital Expenditure: 96085 Open source
20182018-05-31	Free cash flow margin	-23.4%	Revenue: 5564185 Open source Operating Cash Flow: -1174217 Open source Capital Expenditure: 130347 Open source
20192019-05-31	Free cash flow margin	-45.1%	Revenue: 5200682 Open source Operating Cash Flow: -2244039 Open source Capital Expenditure: 101137 Open source
20202020-05-31	Free cash flow margin	-64.7%	Revenue: 6693000 Open source Operating Cash Flow: -4297498 Open source Capital Expenditure: 33608 Open source
20212021-05-31	Free cash flow margin	-74.8%	Revenue: 7199000 Open source Operating Cash Flow: -5251748 Open source Capital Expenditure: 135856 Open source
20222022-05-31	Free cash flow margin	-2.8%	Revenue: 18871000 Open source Operating Cash Flow: -479000 Open source Capital Expenditure: 57000 Open source
20232023-05-31	Free cash flow margin	-103.7%	Revenue: 5339000 Open source Operating Cash Flow: -5474000 Open source Capital Expenditure: 64000 Open source
20242024-05-31	Free cash flow margin	-99.9%	Revenue: 5415000 Open source Operating Cash Flow: -5361000 Open source Capital Expenditure: 51000 Open source
20252025-05-31	Free cash flow margin	Not reported	Revenue: 5311000 Open source Operating Cash Flow: -3842000 Open source
20262026-05-31	Free cash flow margin	Not reported	Revenue: 4453000 Open source Operating Cash Flow: -3421000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.4M 2026

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-05-31	Operating cash flow	-722858	Operating Cash Flow: -722858 Open source
20182018-05-31	Operating cash flow	-1174217	Operating Cash Flow: -1174217 Open source
20192019-05-31	Operating cash flow	-2244039	Operating Cash Flow: -2244039 Open source
20202020-05-31	Operating cash flow	-4297498	Operating Cash Flow: -4297498 Open source
20212021-05-31	Operating cash flow	-5251748	Operating Cash Flow: -5251748 Open source
20222022-05-31	Operating cash flow	-479000	Operating Cash Flow: -479000 Open source
20232023-05-31	Operating cash flow	-5474000	Operating Cash Flow: -5474000 Open source
20242024-05-31	Operating cash flow	-5361000	Operating Cash Flow: -5361000 Open source
20252025-05-31	Operating cash flow	-3842000	Operating Cash Flow: -3842000 Open source
20262026-05-31	Operating cash flow	-3421000	Operating Cash Flow: -3421000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -5.4M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-05-31	Free cash flow	-818943	Operating Cash Flow: -722858 Open source Capital Expenditure: 96085 Open source
20182018-05-31	Free cash flow	-1304564	Operating Cash Flow: -1174217 Open source Capital Expenditure: 130347 Open source
20192019-05-31	Free cash flow	-2345176	Operating Cash Flow: -2244039 Open source Capital Expenditure: 101137 Open source
20202020-05-31	Free cash flow	-4331106	Operating Cash Flow: -4297498 Open source Capital Expenditure: 33608 Open source
20212021-05-31	Free cash flow	-5387604	Operating Cash Flow: -5251748 Open source Capital Expenditure: 135856 Open source
20222022-05-31	Free cash flow	-536000	Operating Cash Flow: -479000 Open source Capital Expenditure: 57000 Open source
20232023-05-31	Free cash flow	-5538000	Operating Cash Flow: -5474000 Open source Capital Expenditure: 64000 Open source
20242024-05-31	Free cash flow	-5412000	Operating Cash Flow: -5361000 Open source Capital Expenditure: 51000 Open source
20252025-05-31	Free cash flow	Unavailable	Operating Cash Flow: -3842000 Open source
20262026-05-31	Free cash flow	Unavailable	Operating Cash Flow: -3421000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

61.1% 2026

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2017-05-31	Liabilities / assets	Not reported	Total Assets: 5017990 Open source
2018-05-31	Liabilities / assets	Not reported	Total Assets: 5222582 Open source
20192019-05-31	Liabilities / assets	24.1%	Total Liabilities: 1264394 Open source Total Assets: 5245364 Open source
20202020-05-31	Liabilities / assets	17.7%	Total Liabilities: 3046825 Open source Total Assets: 17259878 Open source
20212021-05-31	Liabilities / assets	21.9%	Total Liabilities: 2591790 Open source Total Assets: 11818813 Open source
20222022-05-31	Liabilities / assets	26.8%	Total Liabilities: 3049000 Open source Total Assets: 11374000 Open source
20232023-05-31	Liabilities / assets	18.9%	Total Liabilities: 2730000 Open source Total Assets: 14454000 Open source
20242024-05-31	Liabilities / assets	28.8%	Total Liabilities: 2663000 Open source Total Assets: 9254000 Open source
20252025-05-31	Liabilities / assets	31%	Total Liabilities: 1840000 Open source Total Assets: 5945000 Open source
20262026-05-31	Liabilities / assets	61.1%	Total Liabilities: 4129000 Open source Total Assets: 6759000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.62× 2026

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-05-31	Current assets / current liabilities	7.96×	Current Assets: 4210351 Open source Current Liabilities: 528866 Open source
20182018-05-31	Current assets / current liabilities	5×	Current Assets: 4484029 Open source Current Liabilities: 896808 Open source
20192019-05-31	Current assets / current liabilities	3.56×	Current Assets: 4494929 Open source Current Liabilities: 1264394 Open source
20202020-05-31	Current assets / current liabilities	10×	Current Assets: 14766817 Open source Current Liabilities: 1477147 Open source
20212021-05-31	Current assets / current liabilities	7.1×	Current Assets: 9230907 Open source Current Liabilities: 1300220 Open source
20222022-05-31	Current assets / current liabilities	4.69×	Current Assets: 9427000 Open source Current Liabilities: 2011000 Open source
20232023-05-31	Current assets / current liabilities	6.58×	Current Assets: 12797000 Open source Current Liabilities: 1945000 Open source
20242024-05-31	Current assets / current liabilities	3.51×	Current Assets: 7731000 Open source Current Liabilities: 2204000 Open source
20252025-05-31	Current assets / current liabilities	2.8×	Current Assets: 4875000 Open source Current Liabilities: 1740000 Open source
20262026-05-31	Current assets / current liabilities	1.62×	Current Assets: 4016000 Open source Current Liabilities: 2481000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-06-01 – 2017-05-31	−USD 908,561 Exact value Exact value: -908561 USD 2016-06-01 – 2017-05-31: -908561 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2017-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -908561 USD Concept: fundies:NetIncome Period: 2016-06-01 to 2017-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2017-05-31&surface=latest&period_type=duration&start=2016-06-01&unit=USD&dimensions= Input fundies:NetIncome: -908561 USD (2016-06-01 to 2017-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316218000223/bmra-20180531.xml#70157 Filing: 000151316218000223 The citation records this snapshot. The page link may show a newer release later.	−USD 722,858 Exact value Exact value: -722858 USD 2016-06-01 – 2017-05-31: -722858 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2017-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -722858 USD Concept: fundies:OperatingCashFlow Period: 2016-06-01 to 2017-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2017-05-31&surface=latest&period_type=duration&start=2016-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -722858 USD (2016-06-01 to 2017-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316218000223/bmra-20180531.xml#84481 Filing: 000151316218000223 The citation records this snapshot. The page link may show a newer release later.	USD 96,085 Exact value Exact value: 96085 USD 2016-06-01 – 2017-05-31: 96085 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMERICA, INC. · 2017-05-31 BIOMERICA, INC. (edgar:73290) Capital Expenditure: 96085 USD Concept: fundies:CapitalExpenditure Period: 2016-06-01 to 2017-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ACapitalExpenditure&period=2017-05-31&surface=latest&period_type=duration&start=2016-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 96085 USD (2016-06-01 to 2017-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316218000223/bmra-20180531.xml#84844 Filing: 000151316218000223 The citation records this snapshot. The page link may show a newer release later.	−USD 818,943 Calculation and evidence -722858 − 96085 USD Exact free cash flow: -818943 USD 2016-06-01 – 2017-05-31: -722858 USD · Inspect Operating Cash Flow · Source 2016-06-01 – 2017-05-31: 96085 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOMERICA, INC. · 2017-05-31 BIOMERICA, INC. (edgar:73290) Free cash flow: -818943 USD Concept: free-cash-flow Period: 2016-06-01 to 2017-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -722858 USD (2016-06-01 to 2017-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316218000223/bmra-20180531.xml#84481 Filing: 000151316218000223 Input fundies:CapitalExpenditure: 96085 USD (2016-06-01 to 2017-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316218000223/bmra-20180531.xml#84844 Filing: 000151316218000223 The citation records this snapshot. The page link may show a newer release later.
2018 2017-06-01 – 2018-05-31	−USD 1.47 million Exact value Exact value: -1465828 USD 2017-06-01 – 2018-05-31: -1465828 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2018-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -1465828 USD Concept: fundies:NetIncome Period: 2017-06-01 to 2018-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2018-05-31&surface=latest&period_type=duration&start=2017-06-01&unit=USD&dimensions= Input fundies:NetIncome: -1465828 USD (2017-06-01 to 2018-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316219000194/bmra-20190531.xml#87646 Filing: 000151316219000194 The citation records this snapshot. The page link may show a newer release later.	−USD 1.17 million Exact value Exact value: -1174217 USD 2017-06-01 – 2018-05-31: -1174217 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2018-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -1174217 USD Concept: fundies:OperatingCashFlow Period: 2017-06-01 to 2018-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2018-05-31&surface=latest&period_type=duration&start=2017-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1174217 USD (2017-06-01 to 2018-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316219000194/bmra-20190531.xml#103209 Filing: 000151316219000194 The citation records this snapshot. The page link may show a newer release later.	USD 130,347 Exact value Exact value: 130347 USD 2017-06-01 – 2018-05-31: 130347 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMERICA, INC. · 2018-05-31 BIOMERICA, INC. (edgar:73290) Capital Expenditure: 130347 USD Concept: fundies:CapitalExpenditure Period: 2017-06-01 to 2018-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ACapitalExpenditure&period=2018-05-31&surface=latest&period_type=duration&start=2017-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 130347 USD (2017-06-01 to 2018-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316219000194/bmra-20190531.xml#103850 Filing: 000151316219000194 The citation records this snapshot. The page link may show a newer release later.	−USD 1.3 million Calculation and evidence -1174217 − 130347 USD Exact free cash flow: -1304564 USD 2017-06-01 – 2018-05-31: -1174217 USD · Inspect Operating Cash Flow · Source 2017-06-01 – 2018-05-31: 130347 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOMERICA, INC. · 2018-05-31 BIOMERICA, INC. (edgar:73290) Free cash flow: -1304564 USD Concept: free-cash-flow Period: 2017-06-01 to 2018-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1174217 USD (2017-06-01 to 2018-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316219000194/bmra-20190531.xml#103209 Filing: 000151316219000194 Input fundies:CapitalExpenditure: 130347 USD (2017-06-01 to 2018-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316219000194/bmra-20190531.xml#103850 Filing: 000151316219000194 The citation records this snapshot. The page link may show a newer release later.
2019 2018-06-01 – 2019-05-31	−USD 2.39 million Exact value Exact value: -2393060 USD 2018-06-01 – 2019-05-31: -2393060 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2019-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -2393060 USD Concept: fundies:NetIncome Period: 2018-06-01 to 2019-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2019-05-31&surface=latest&period_type=duration&start=2018-06-01&unit=USD&dimensions= Input fundies:NetIncome: -2393060 USD (2018-06-01 to 2019-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316220000185/bmra-20200531.xml#122652 Filing: 000151316220000185 The citation records this snapshot. The page link may show a newer release later.	−USD 2.24 million Exact value Exact value: -2244039 USD 2018-06-01 – 2019-05-31: -2244039 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2019-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -2244039 USD Concept: fundies:OperatingCashFlow Period: 2018-06-01 to 2019-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2019-05-31&surface=latest&period_type=duration&start=2018-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2244039 USD (2018-06-01 to 2019-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316220000185/bmra-20200531.xml#140531 Filing: 000151316220000185 The citation records this snapshot. The page link may show a newer release later.	USD 101,137 Exact value Exact value: 101137 USD 2018-06-01 – 2019-05-31: 101137 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMERICA, INC. · 2019-05-31 BIOMERICA, INC. (edgar:73290) Capital Expenditure: 101137 USD Concept: fundies:CapitalExpenditure Period: 2018-06-01 to 2019-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ACapitalExpenditure&period=2019-05-31&surface=latest&period_type=duration&start=2018-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 101137 USD (2018-06-01 to 2019-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316220000185/bmra-20200531.xml#141226 Filing: 000151316220000185 The citation records this snapshot. The page link may show a newer release later.	−USD 2.35 million Calculation and evidence -2244039 − 101137 USD Exact free cash flow: -2345176 USD 2018-06-01 – 2019-05-31: -2244039 USD · Inspect Operating Cash Flow · Source 2018-06-01 – 2019-05-31: 101137 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOMERICA, INC. · 2019-05-31 BIOMERICA, INC. (edgar:73290) Free cash flow: -2345176 USD Concept: free-cash-flow Period: 2018-06-01 to 2019-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2244039 USD (2018-06-01 to 2019-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316220000185/bmra-20200531.xml#140531 Filing: 000151316220000185 Input fundies:CapitalExpenditure: 101137 USD (2018-06-01 to 2019-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316220000185/bmra-20200531.xml#141226 Filing: 000151316220000185 The citation records this snapshot. The page link may show a newer release later.
2020 2019-06-01 – 2020-05-31	−USD 2.68 million Exact value Exact value: -2677171 USD 2019-06-01 – 2020-05-31: -2677171 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2020-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -2677171 USD Concept: fundies:NetIncome Period: 2019-06-01 to 2020-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2020-05-31&surface=latest&period_type=duration&start=2019-06-01&unit=USD&dimensions= Input fundies:NetIncome: -2677171 USD (2019-06-01 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316221000127/bmra-20210531.xml#164972 Filing: 000151316221000127 The citation records this snapshot. The page link may show a newer release later.	−USD 4.3 million Exact value Exact value: -4297498 USD 2019-06-01 – 2020-05-31: -4297498 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2020-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -4297498 USD Concept: fundies:OperatingCashFlow Period: 2019-06-01 to 2020-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2020-05-31&surface=latest&period_type=duration&start=2019-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4297498 USD (2019-06-01 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316221000127/bmra-20210531.xml#175786 Filing: 000151316221000127 The citation records this snapshot. The page link may show a newer release later.	USD 33,608 Exact value Exact value: 33608 USD 2019-06-01 – 2020-05-31: 33608 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMERICA, INC. · 2020-05-31 BIOMERICA, INC. (edgar:73290) Capital Expenditure: 33608 USD Concept: fundies:CapitalExpenditure Period: 2019-06-01 to 2020-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ACapitalExpenditure&period=2020-05-31&surface=latest&period_type=duration&start=2019-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33608 USD (2019-06-01 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316221000127/bmra-20210531.xml#176483 Filing: 000151316221000127 The citation records this snapshot. The page link may show a newer release later.	−USD 4.33 million Calculation and evidence -4297498 − 33608 USD Exact free cash flow: -4331106 USD 2019-06-01 – 2020-05-31: -4297498 USD · Inspect Operating Cash Flow · Source 2019-06-01 – 2020-05-31: 33608 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOMERICA, INC. · 2020-05-31 BIOMERICA, INC. (edgar:73290) Free cash flow: -4331106 USD Concept: free-cash-flow Period: 2019-06-01 to 2020-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4297498 USD (2019-06-01 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316221000127/bmra-20210531.xml#175786 Filing: 000151316221000127 Input fundies:CapitalExpenditure: 33608 USD (2019-06-01 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316221000127/bmra-20210531.xml#176483 Filing: 000151316221000127 The citation records this snapshot. The page link may show a newer release later.
2021 2020-06-01 – 2021-05-31	−USD 7.45 million Exact value Exact value: -7446254 USD 2020-06-01 – 2021-05-31: -7446254 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2021-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -7446254 USD Concept: fundies:NetIncome Period: 2020-06-01 to 2021-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2021-05-31&surface=latest&period_type=duration&start=2020-06-01&unit=USD&dimensions= Input fundies:NetIncome: -7446254 USD (2020-06-01 to 2021-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316222000114/bmra-20220531.htm#777527 Filing: 000151316222000114 The citation records this snapshot. The page link may show a newer release later.	−USD 5.25 million Exact value Exact value: -5251748 USD 2020-06-01 – 2021-05-31: -5251748 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2021-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -5251748 USD Concept: fundies:OperatingCashFlow Period: 2020-06-01 to 2021-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2021-05-31&surface=latest&period_type=duration&start=2020-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5251748 USD (2020-06-01 to 2021-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316222000114/bmra-20220531.htm#811901 Filing: 000151316222000114 The citation records this snapshot. The page link may show a newer release later.	USD 135,856 Exact value Exact value: 135856 USD 2020-06-01 – 2021-05-31: 135856 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMERICA, INC. · 2021-05-31 BIOMERICA, INC. (edgar:73290) Capital Expenditure: 135856 USD Concept: fundies:CapitalExpenditure Period: 2020-06-01 to 2021-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ACapitalExpenditure&period=2021-05-31&surface=latest&period_type=duration&start=2020-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 135856 USD (2020-06-01 to 2021-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316222000114/bmra-20220531.htm#819413 Filing: 000151316222000114 The citation records this snapshot. The page link may show a newer release later.	−USD 5.39 million Calculation and evidence -5251748 − 135856 USD Exact free cash flow: -5387604 USD 2020-06-01 – 2021-05-31: -5251748 USD · Inspect Operating Cash Flow · Source 2020-06-01 – 2021-05-31: 135856 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOMERICA, INC. · 2021-05-31 BIOMERICA, INC. (edgar:73290) Free cash flow: -5387604 USD Concept: free-cash-flow Period: 2020-06-01 to 2021-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5251748 USD (2020-06-01 to 2021-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316222000114/bmra-20220531.htm#811901 Filing: 000151316222000114 Input fundies:CapitalExpenditure: 135856 USD (2020-06-01 to 2021-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000151316222000114/bmra-20220531.htm#819413 Filing: 000151316222000114 The citation records this snapshot. The page link may show a newer release later.
2022 2021-06-01 – 2022-05-31	−USD 4.53 million Exact value Exact value: -4531000 USD 2021-06-01 – 2022-05-31: -4531000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2022-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -4531000 USD Concept: fundies:NetIncome Period: 2021-06-01 to 2022-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2022-05-31&surface=latest&period_type=duration&start=2021-06-01&unit=USD&dimensions= Input fundies:NetIncome: -4531000 USD (2021-06-01 to 2022-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315223030254/form10-k.htm#769104 Filing: 000149315223030254 The citation records this snapshot. The page link may show a newer release later.	−USD 479,000 Exact value Exact value: -479000 USD 2021-06-01 – 2022-05-31: -479000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2022-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -479000 USD Concept: fundies:OperatingCashFlow Period: 2021-06-01 to 2022-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2022-05-31&surface=latest&period_type=duration&start=2021-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -479000 USD (2021-06-01 to 2022-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315223030254/form10-k.htm#793575 Filing: 000149315223030254 The citation records this snapshot. The page link may show a newer release later.	USD 57,000 Exact value Exact value: 57000 USD 2021-06-01 – 2022-05-31: 57000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMERICA, INC. · 2022-05-31 BIOMERICA, INC. (edgar:73290) Capital Expenditure: 57000 USD Concept: fundies:CapitalExpenditure Period: 2021-06-01 to 2022-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ACapitalExpenditure&period=2022-05-31&surface=latest&period_type=duration&start=2021-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 57000 USD (2021-06-01 to 2022-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315223030254/form10-k.htm#798828 Filing: 000149315223030254 The citation records this snapshot. The page link may show a newer release later.	−USD 536,000 Calculation and evidence -479000 − 57000 USD Exact free cash flow: -536000 USD 2021-06-01 – 2022-05-31: -479000 USD · Inspect Operating Cash Flow · Source 2021-06-01 – 2022-05-31: 57000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOMERICA, INC. · 2022-05-31 BIOMERICA, INC. (edgar:73290) Free cash flow: -536000 USD Concept: free-cash-flow Period: 2021-06-01 to 2022-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -479000 USD (2021-06-01 to 2022-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315223030254/form10-k.htm#793575 Filing: 000149315223030254 Input fundies:CapitalExpenditure: 57000 USD (2021-06-01 to 2022-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315223030254/form10-k.htm#798828 Filing: 000149315223030254 The citation records this snapshot. The page link may show a newer release later.
2023 2022-06-01 – 2023-05-31	−USD 7.14 million Exact value Exact value: -7140000 USD 2022-06-01 – 2023-05-31: -7140000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2023-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -7140000 USD Concept: fundies:NetIncome Period: 2022-06-01 to 2023-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2023-05-31&surface=latest&period_type=duration&start=2022-06-01&unit=USD&dimensions= Input fundies:NetIncome: -7140000 USD (2022-06-01 to 2023-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315224034208/form10-k.htm#664478 Filing: 000149315224034208 The citation records this snapshot. The page link may show a newer release later.	−USD 5.47 million Exact value Exact value: -5474000 USD 2022-06-01 – 2023-05-31: -5474000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2023-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -5474000 USD Concept: fundies:OperatingCashFlow Period: 2022-06-01 to 2023-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2023-05-31&surface=latest&period_type=duration&start=2022-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5474000 USD (2022-06-01 to 2023-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315224034208/form10-k.htm#678890 Filing: 000149315224034208 The citation records this snapshot. The page link may show a newer release later.	USD 64,000 Exact value Exact value: 64000 USD 2022-06-01 – 2023-05-31: 64000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMERICA, INC. · 2023-05-31 BIOMERICA, INC. (edgar:73290) Capital Expenditure: 64000 USD Concept: fundies:CapitalExpenditure Period: 2022-06-01 to 2023-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ACapitalExpenditure&period=2023-05-31&surface=latest&period_type=duration&start=2022-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 64000 USD (2022-06-01 to 2023-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315224034208/form10-k.htm#680767 Filing: 000149315224034208 The citation records this snapshot. The page link may show a newer release later.	−USD 5.54 million Calculation and evidence -5474000 − 64000 USD Exact free cash flow: -5538000 USD 2022-06-01 – 2023-05-31: -5474000 USD · Inspect Operating Cash Flow · Source 2022-06-01 – 2023-05-31: 64000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOMERICA, INC. · 2023-05-31 BIOMERICA, INC. (edgar:73290) Free cash flow: -5538000 USD Concept: free-cash-flow Period: 2022-06-01 to 2023-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5474000 USD (2022-06-01 to 2023-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315224034208/form10-k.htm#678890 Filing: 000149315224034208 Input fundies:CapitalExpenditure: 64000 USD (2022-06-01 to 2023-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315224034208/form10-k.htm#680767 Filing: 000149315224034208 The citation records this snapshot. The page link may show a newer release later.
2024 2023-06-01 – 2024-05-31	−USD 5.98 million Exact value Exact value: -5978000 USD 2023-06-01 – 2024-05-31: -5978000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2024-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -5978000 USD Concept: fundies:NetIncome Period: 2023-06-01 to 2024-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2024-05-31&surface=latest&period_type=duration&start=2023-06-01&unit=USD&dimensions= Input fundies:NetIncome: -5978000 USD (2023-06-01 to 2024-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000164117225026041/form10-k.htm#1120907 Filing: 000164117225026041 The citation records this snapshot. The page link may show a newer release later.	−USD 5.36 million Exact value Exact value: -5361000 USD 2023-06-01 – 2024-05-31: -5361000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2024-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -5361000 USD Concept: fundies:OperatingCashFlow Period: 2023-06-01 to 2024-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2024-05-31&surface=latest&period_type=duration&start=2023-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5361000 USD (2023-06-01 to 2024-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000164117225026041/form10-k.htm#879340 Filing: 000164117225026041 The citation records this snapshot. The page link may show a newer release later.	USD 51,000 Exact value Exact value: 51000 USD 2023-06-01 – 2024-05-31: 51000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMERICA, INC. · 2024-05-31 BIOMERICA, INC. (edgar:73290) Capital Expenditure: 51000 USD Concept: fundies:CapitalExpenditure Period: 2023-06-01 to 2024-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ACapitalExpenditure&period=2024-05-31&surface=latest&period_type=duration&start=2023-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51000 USD (2023-06-01 to 2024-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000164117225026041/form10-k.htm#884169 Filing: 000164117225026041 The citation records this snapshot. The page link may show a newer release later.	−USD 5.41 million Calculation and evidence -5361000 − 51000 USD Exact free cash flow: -5412000 USD 2023-06-01 – 2024-05-31: -5361000 USD · Inspect Operating Cash Flow · Source 2023-06-01 – 2024-05-31: 51000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOMERICA, INC. · 2024-05-31 BIOMERICA, INC. (edgar:73290) Free cash flow: -5412000 USD Concept: free-cash-flow Period: 2023-06-01 to 2024-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5361000 USD (2023-06-01 to 2024-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000164117225026041/form10-k.htm#879340 Filing: 000164117225026041 Input fundies:CapitalExpenditure: 51000 USD (2023-06-01 to 2024-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000164117225026041/form10-k.htm#884169 Filing: 000164117225026041 The citation records this snapshot. The page link may show a newer release later.
2025 2024-06-01 – 2025-05-31	−USD 4.97 million Exact value Exact value: -4973000 USD 2024-06-01 – 2025-05-31: -4973000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2025-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -4973000 USD Concept: fundies:NetIncome Period: 2024-06-01 to 2025-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2025-05-31&surface=latest&period_type=duration&start=2024-06-01&unit=USD&dimensions= Input fundies:NetIncome: -4973000 USD (2024-06-01 to 2025-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#1040542 Filing: 000149315226040851 The citation records this snapshot. The page link may show a newer release later.	−USD 3.84 million Exact value Exact value: -3842000 USD 2024-06-01 – 2025-05-31: -3842000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2025-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -3842000 USD Concept: fundies:OperatingCashFlow Period: 2024-06-01 to 2025-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2025-05-31&surface=latest&period_type=duration&start=2024-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3842000 USD (2024-06-01 to 2025-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#851307 Filing: 000149315226040851 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2026 2025-06-01 – 2026-05-31	−USD 3.78 million Exact value Exact value: -3775000 USD 2025-06-01 – 2026-05-31: -3775000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMERICA, INC. · 2026-05-31 BIOMERICA, INC. (edgar:73290) Net Income: -3775000 USD Concept: fundies:NetIncome Period: 2025-06-01 to 2026-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3ANetIncome&period=2026-05-31&surface=latest&period_type=duration&start=2025-06-01&unit=USD&dimensions= Input fundies:NetIncome: -3775000 USD (2025-06-01 to 2026-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#1040103 Filing: 000149315226040851 The citation records this snapshot. The page link may show a newer release later.	−USD 3.42 million Exact value Exact value: -3421000 USD 2025-06-01 – 2026-05-31: -3421000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOMERICA, INC. · 2026-05-31 BIOMERICA, INC. (edgar:73290) Operating Cash Flow: -3421000 USD Concept: fundies:OperatingCashFlow Period: 2025-06-01 to 2026-05-31 Values: Latest reported Published: 2026-11-02T12:06:24Z Snapshot: 3985b762f11a22697bb58e5d7431dbf1d8ea3dbd6287f083e1f018f21e4cd167 Dimensions: Consolidated View: https://fundies.io/companies/edgar/73290/explain?concept=fundies%3AOperatingCashFlow&period=2026-05-31&surface=latest&period_type=duration&start=2025-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3421000 USD (2025-06-01 to 2026-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/73290/000149315226040851/form10-k.htm#850844 Filing: 000149315226040851 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

146 filings · 5,651 latest values · 5,651 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000073290, 73290, BMRA, edgar:73290

Also known as BIOMERICA INC, BIOMERICA INC., BIOMERICA, INC.

BIOMERICA, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2026 2025-06-01 – 2026-05-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation